|
Association between epigenomic biomarkers and baseline clinical characteristics in patients with mCRPC treated with rucaparib in TRITON2. |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Travel, Accommodations, Expenses - Guardant Health |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
| |
|
No Relationships to Disclose |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Patents, Royalties, Other Intellectual Property - Guardant Health |
| |
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |